In the world of Parkinson’s disease, mild cognitive impairment (MCI) is like stepping stones on a path. It marks the transition stage between normal aging and full-blown dementia, and it serves as a powerful predictor of what lies ahead. While MCI has long been used to describe certain PD symptoms, consistent diagnostic criteria have been […]
Imagine you’re an old car that’s been through a lot of wear and tear. You’ve had some surgeries, maybe a few dings and dents. But then, along comes a young, fresh engine that restores your power! That’s what happened to aged rats in this study. Researchers found that when aged rats received infusions of young […]
Imagine early-onset Alzheimer’s disease (EOAD) as a perplexing puzzle with genetic variants as its missing pieces. EOAD, the most common form of early-onset dementia, has been studied extensively, yet many patients still lack a clear genetic explanation. In this study, researchers delved into the genetic landscape of 102 Italian EOAD patients, analyzing a panel of […]
© 2024 BETTER/SMARTER.ME, A division of the Institute for the Future of Human Potential
200 First St. SW Rochester, MN 55905 | 1-800-328-IFHP
IFHRP research has not been evaluated by the Food and Drug Administration or any government agency.
IFHRP research is not intended to diagnose, treat, cure, or prevent disease.